This study is currently not recruiting participants.

A Phase 3 Multicenter Double-Blind Placebo-Controlled Single-Treatment Efficacy and Safety Study of MYOBLOC (Part A) Followed by Open-Label Multiple-Treatment with MYOBLOC (Part B) in the Treatment of Troublesome Sialorrhea in Adult Subjects

Not Recruiting
18 years - 85 years
All
Phase N/A

Brief description of study.

The purpose of this study is to learn if MYOBLOC can help to reduce or lessen the amount of saliva produced by the salivary glands.

Detailed description of study

The purpose of this research study is to learn if MYOBLOC can help to reduce or lessen the amount of saliva produced by the salivary glands. In addition, this study will compare MYOBLOC with a placebo to see if receiving MYOBLOC is better than receiving placebo.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: sialorrhea
  • Age: 18 years - 85 years
  • Gender: All
Updated on 18 Aug 2014. Study ID: 1405059674

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team